Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sei Keng Koh"'
Autor:
May Anne Cheong, Chuen Wen Tan, Wan Hui Wong, Ming Chai Kong, Edmund See, Shu Hui Yeang, Sei Keng Koh, Yuan Tying Shim, Lai Heng Lee, Heng Joo Ng
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 337-342 (2022)
Objectives Thrombin generation assays and activated partial thromboplastin time (aPTT)-based clot waveform analysis (CWA), are some examples of global coagulation assays. Each modality evaluates different aspects of the clot forming process to global
Externí odkaz:
https://doaj.org/article/2b9fa31a1eb147c29ebbe6e58b4714e1
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2008, Iss Issue 3, Pp 653-657 (2008)
Alex C Spyropoulos1, Sharyl Magnuson1, Sei Keng Koh21Clinical Thrombosis Center, Lovelace Medical Center, Albuquerque, NM, USA; 2Department of Pharmacy, Singapore General Hospital, SingaporeAbstract: Heparin-induced thrombocytopenia (HIT) is an immun
Externí odkaz:
https://doaj.org/article/a40dda2f725e4a868dd127feea32dc5b
Autor:
Giat Yeng Khee, Paik Shia Lim, Jia Yuan Tay, Melissa Mee Yin Chow, Wan Chee Ong, Sei Keng Koh
Publikováno v:
The Asia Pacific Scholar. 2:16-20
Autor:
Chuen Wen Tan, Heng Joo Ng, Fiona Seet Ling Chan, Shu Hui Yeang, Sei Keng Koh, Yuan Tying Shim, Clifton Xuan You Liew, Liam Pock Ho, Hartirathpal Kaur, Yi Feng Lai, Chin Pin Yeo, Wai Yoong Ng, Wan Hui Wong, Ming Chai Kong, Edmund See, Hui Ming Tay
Publikováno v:
Journal of clinical pathology. 72(4)
Point-of-care testing (POCT) of the international normalised ratio (INR) is recognised as a rapid and reliable alternative to venous INR measurement for titration and monitoring of patients anticoagulated with vitamin K antagonists.1–4 Besides empo
Publikováno v:
Journal of Thrombosis and Thrombolysis. 30:354-357
Temporary interruption of anticoagulation therapy is usually recommended for anticoagulated patients undergoing invasive procedures to minimize their bleeding risks. We validated the current consensus recommendation on warfarin interruption which wer
Publikováno v:
Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management, Vol 2008, Iss Issue 3, Pp 653-657 (2008)
Therapeutics and Clinical Risk Management, Vol 2008, Iss Issue 3, Pp 653-657 (2008)
Alex C Spyropoulos1, Sharyl Magnuson1, Sei Keng Koh21Clinical Thrombosis Center, Lovelace Medical Center, Albuquerque, NM, USA; 2Department of Pharmacy, Singapore General Hospital, SingaporeAbstract: Heparin-induced thrombocytopenia (HIT) is an immun
Autor:
Hui Ming Tay, Yi Feng Lai, Ming Chai Kong, Edmund See, Shu Hui Yeang, Sei Keng Koh, Yuan Tying Shim, Fiona Seet Ling Chan, Wan Hui Wong, Clifton Xuan You Liew, Hartirathpal Kaur, Chuen Wen Tan, Liam Pock Ho, Wai Yoong Ng, Chin Pin Yeo, Heng Joo Ng
Publikováno v:
Journal of Clinical Pathology; Apr2019, Vol. 72 Issue 4, p311-315, 5p
Publikováno v:
MedEdPublish. 6:138
This article was migrated. The article was marked as recommended. Competency frameworks is implemented to support continuing professional development in an academic medical centre, with the aims of establishing and retaining a competent pharmacist wo
Publikováno v:
Therapeutics & Clinical Risk Management; 2008, Vol. 4 Issue 3, p653-657, 5p